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Abstract: Saxitoxin (STX) and its analogs are paralytic alkaloid neurotoxins that block the
voltage-gated sodium channel pore (Nav), impeding passage of Na+ ions into the intracellular
space, and thereby preventing the action potential in the peripheral nervous system and skeletal
muscle. The marine dinoflagellate Gymnodinium catenatum produces an array of such toxins, including
the recently discovered benzoyl analogs, for which the mammalian toxicities are essentially unknown.
We subjected STX and its analogs to a theoretical docking simulation based upon two alternative
tri-dimensional models of the Nav1.4 to find a relationship between the binding properties and
the known mammalian toxicity of selected STX analogs. We inferred hypothetical toxicities for the
benzoyl analogs from the modeled values. We demonstrate that these toxins exhibit different binding
modes with similar free binding energies and that these alternative binding modes are equally
probable. We propose that the principal binding that governs ligand recognition is mediated by
electrostatic interactions. Our simulation constitutes the first in silico modeling study on benzoyl-type
paralytic toxins and provides an approach towards a better understanding of the mode of action of
STX and its analogs.
Keywords: voltage-gated sodium channel; benzoyl saxitoxin analogs; molecular docking;
binding affinity
1. Introduction
Saxitoxin (STX) and its numerous naturally occurring analogs are alkaloids with neurotoxic
properties. These toxins are hetero-tricycles with two guanidinium groups that are positively charged at
physiological pH (~7). The guanidinium groups are responsible for toxin polarity and water solubility,
and are essential for sodium channel binding properties. These toxins also have two hydroxyl groups
at the C-12 position that are critical for binding to the sodium channel [1].
Intoxication by these toxins can be severe and occasionally fatal for consumers of contaminated
shellfish [2]. Typically, the toxins affect humans after consuming bivalve shellfish that have ingested
toxic dinoflagellates during a harmful algal bloom, thus they are known colloquially as paralytic
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shellfish toxins (PSTs), but rare cases of poisoning can also occur from eating contaminated fish or
crustaceans [3].
In the marine environment, PSTs are produced by free-living dinoflagellates belonging to
three genera [4]. These toxigenic dinoflagellates include about a dozen species of the gonyaulacoid
genus Alexandrium, plus the heavily armored species Pyrodinium bahamense (P. bahamense) and the
naked chain-forming Gymnodinium catenatum (G. catenatum), the only PST-producing gymnodinoid
dinoflagellate [5].
At least 57 naturally occurring PST analogs have been identified in diverse aquatic and terrestrial
organisms [6,7]. These analogs have been subdivided according to their chemical substituent groups
on the lateral chain, as carbamoyl, decarbamoyl, N-sulfocarbamoyl, or benzoyl (p-hydroxybenzoyl,
di-hydroxybenzoyl, or sulfobenzoyl) derivatives. Variation in the substituent groups confers different
toxin potency in mammalian systems, ranging in relative toxicity from the most potent, STX, to the least
potent, N-sulfocarbamoyl derivatives, usually determined by intraperitoneal injection into laboratory
mice [8].
Benzoyl toxins (also called GC toxins) have been exclusively identified in strains of G. catenatum [9–13].
Chemical characterization and confirmed identification of these analogs has been limited, mainly
due to the lack of analytical standards [14]. Currently, three structures have been unequivocally
determined by nuclear magnetic resonance (NMR) [9] and another 15 putative structures have been
proposed based upon mass spectrometry [11,15], but the specific toxicity of these putative analogs is
still unknown.
Voltage-gated sodium channels (Nav), the main target for PSTs, are present in excitable cell
membranes. The voltage-gated channel proteins provide the main current underlying rapid signal
propagation, and consist of a ~230 kD α-subunit that forms the pore with the selectivity filter, where
the binding sites for multiple drugs and toxins are found [16]. The domains are thought to be organized
circumferentially around the ion-conducting pore. The amino acid chains that line the ion permeation
pathway are known as the P-loops [17]. A water-filled region encompassed by the four P-loops forms
the outer vestibule of the channel. The outer vestibule is the region of the α-subunit that includes the
receptors for site 1 sodium channel blockers such as tetrodotoxin (TTX) and STX [16].
Given the lack of information on toxicity and mode of action on their biological target of these
recently discovered GC analogs, theoretical studies are essential to decipher the recognition and
binding patterns. Studies with selected STX analogs have shown strong binding affinities to the Nav
channel [18]. As there is no mammalian model for this voltage gated channel, homology models have
been proposed. These models are based on the crystal structures of bacterial Nav channels, and help
to interpret and understand their functional mechanisms. Such models are useful in structure-based
design of therapeutics [19] and, in the present case, to gain knowledge about specific toxicity of
derivatives, such as benzoyl STX analogs that have not been subjected to in vivo trials.
The PSTs are selective blocking agents that reduce functional Nav channels, while occupying a
site near the channel opening with a 1:1 affinity in the binding site 1 [20,21]. STX and its analogs are
proposed [22] to bind to the same site on Nav because of their similar chemical structures, but with
different affinities. Cloning the family of mammalian Na+ channel genes has led to identification of
four key residues in the selectivity region known as an aspartate-glutamate-lysine-alanine (DEKA)
motif. This motif consists of one amino acid from each of the four P-loop regions from domains I–IV,
respectively, Asp400 (D400), Glu755 (E755), Lys1237 (K1237), and Ala1529 (A1529) [21].
Current docking programs consider the protein as a rigid body and the ligand as a flexible
molecule, which reduces the computational cost by omitting conformational changes that occur in
protein molecules due to ligand binding [23]. Although such proteins may be in fact somewhat flexible,
such docking simulations are very useful for prediction of ligand-protein interactions, providing an
opportunity to explore recognition properties and identify potential pharmacophores [24]. As this
is the first attempt to apply molecular tools in assessing channel binding properties and consequent
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toxicity of recently discovered toxin analogs, namely benzoyl derivatives, these docking simulations
are a suitable tool for a first approach.
With scarce information on the recognition of STX and its analogs at the channel binding site,
we performed molecular docking studies with two alternative Nav1.4 models, to depict the kinds
of interactions that govern their recognition. Our hypothesis is that the guanidinium groups with
positive charges and sulfate groups with negative charges engage in electrostatic interactions with
basic or acidic residues located in the Nav recognition site.
2. Results
2.1. Interaction of STX and Analogs with Nav1.4 Amino Acid Residues
All analogs interacted with the Nav1.4 residues with both models, but to a different extent.
The results of these interactions are explained for each model in the following sections.
2.1.1. Nav1.4 Model 1
The three independent docking simulations showed an average of 22 and a maximum of 25 Nav
1.4 channel residues interacting with the toxin analogs. The residues that showed interactions with
>80% of the PST analogs were D400, K1237, E403, E755, and E758 (Figure 1). Of these residues, D400,
E755, and K1237 correspond to the DEKA selectivity filter ring, along with A1529, which showed much
less interaction, whereas E403 and E758 are part of the outer ring possessing a negative charge. Most of
the residues involved in binding to the toxins belong to P-loops I and II (eight and seven residues,
respectively); these residues interacted with more toxins than the residues from P-loops III and IV,
except for K1237 in P-loop III, which interacted with 92.4% of the toxins in the docking simulations.
Figure 2a–g shows that STX and some of its analogs reach the side-chain with their guanidinium group
of some residues (E403, D400, E755) by electrostatic interactions, whereas there are hydrogen bonds
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Figure 1. Residues and P-loops involved in bindi interaction with saxito in(STX) and its a alogs in
Nav1.4 Model 1. Percentages represent the average number of residues in the three dockings studies.






1  according  to  this  docking  study:  (a)  STX;  (b)  decarbamoyl  saxitoxin  (dcSTX);  (c)  gonyautoxin 
(GTX4);  (d)  C2  toxin  (C2);  (e)  p‐hydroxybenzoyl  (GC1);  (f)  di‐hydroxybenzoyl  (GC3a);  and  (g) 
sulfobenzoyl (GC1b) toxins. Spheres = toxins; sticks = Nav residues. These toxins represent those that 
have the lowest ΔG values per family of toxins and for which the main non‐bond interactions between 








Figure 2. Binding of saxitoxin (STX) and some of its analogs with the residues from the Nav1.4 Model
1 according to this docking study: (a) STX; (b) decarbamoyl saxitoxin (dcSTX); (c) gonyautoxin (GTX4);
(d) C2 toxin (C2); (e) p-hydroxybenzoyl (GC1); (f) di-hydroxybenzoyl (GC3a); and (g) sulfobenzoyl
(GC1b) toxins. Spheres = toxins; sticks = Nav residues. These toxins represent those that have the lowest
∆G values per family of toxins and for which the main non-bond interactions between guanidinium
and E403, D400, E258, as well as between sulfate groups and K1237 and R394, are electrostatic.
2.1.2. Nav1.4 Model 2
According to Model 2, PST analogs showed more interactions with the Nav1.4 channel residues
than for the initial model. This docking simulation showed interactions with 43 residues rather than
the maximum 25 residues with Model 1. Only two residues interacted with >80% of the toxin analogs,
namely D400 and K1237, both from the DEKA selectivity filter ring, whereas E755 and A1529, also
part of the DEKA ring, showed interaction with <20% of the analogs in Model 2 (Figure 3).
The residues that showed interactions with between 60% to 80% of the toxins were C753, G754,
N758 and F1236; all of these residues belong to P-loops II and III. Figure 4a–f also shows that, according
to this model, STX and some analogs reach the side chain with their guanidinium group by electrostatic
interaction and that the hydroxyl group at C-12 forms hydrogen bonds with the residues.




Figure  3. Residues  and P‐loops  involved  in binding  interaction with  saxitoxin  and  its  analogs  in 
Nav1.4 Model 2. 
The residues that showed interactions with between 60% to 80% of the toxins were C753, G754, 
N758  and  F1236;  all  of  these  residues  belong  to P‐loops  II  and  III.  Figure  4a–f  also  shows  that, 
according to this model, STX and some analogs reach the side chain with their guanidinium group 
by  electrostatic  interaction  and  that  the hydroxyl group  at C‐12  forms hydrogen bonds with  the 
residues. 
















Figure 4. Binding of STX and some of its analogs with the residues from the Nav1.4 Model 2 according
to this docking study: (a) STX; (b) decarbamoyl saxitoxin (dcSTX); (c) B toxin (B2); (d) p-hydroxybenzoyl
(GC6); (e) di-hydroxybenzoyl (GC3a); and (f) sulfobenzoyl (GC5b). Spheres = toxins; sticks = Nav
residues. These toxins represent those that have th lowest ∆G values per family of toxins and for
which the main non-bond interactions are electrostatic, e.g., between guanidinium and E403 and D400,
except for GC3a, as well as between sulfate groups and K1237, except for GC5b.
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2.1.3. Comparison between Model 1 and Model 2
There are great differences between the results obtained via Model 1 versus Model 2, even when
the differences in the residues that form these two channel models are not apparently very large.
In Model 1, there was an average of 22 channel residues interacting with all toxin analogs (Figure 5),
whereas in Model 2, 43 residues (almost double in number) interacted with all tested PST analogs.



















Figure 5. Total number of interacting residues in odel 1 (light gray) versus Model 2 (dark gray) in
each P-loop.
The total interactions, i.e., the sum of ll i teractions of all analogs with all residues, w re greater
with Model 2 as well. In M del 1, ther was an average of 247 interactions, whereas Model 2 indicated




















Figure 6. Total number of interactions per P-loop in the two models. Model 1 (light gray) and Model 2
(dark gray).
2.2. Binding Free Energy
2.2.1. Nav1.4 Model
This model exhibited high affinity values for STX and some of its analogs, ranging from ´7.3 to
´16.3 kcal¨mol´1. The sulfobenzoyl derivatives GC3b and GC1b showed unexpected high ∆G values
of ´16.3 kcal¨mol´1. The known most potent analogs, STX, neosaxitoxin (NEO), and decarbamoyl
saxitoxin (dcSTX), which have relative toxicities of ~1 [25] showed similar average ∆G values between
´12.1 and ´12.7 kcal¨mol´1 (Figure 7). For each structural family, the ligands that had the lowest ∆Gs
were GC3b/GC1b < GC3a/GC1 < C2 < GTX4 < dcSTX.
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toxins;  gray  bars,  decarbamoyl  toxins;  diagonal  hatching,  benzoyl  toxins.  The most  potent  PST, 
saxitoxin (STX), is shown in the dotted bar. Numbers indicate the lowest ΔG in each group compared 
with that of STX. 
i re 7. ree- i i e er (∆ , cal¨ l´1) of the docked toxins with Model 1. Toxins are r e
r i t t ir l t r l i : t rs, car l t i s; ri t l tc i , - lf r l
t i ; , r oyl toxins; diagonal hatching, benzoyl toxins. The most potent PST, STX, is
shown i the dotted bar. Numbers indicate th lowest ∆G in each group compared with that of STX.
2.2.2. Nav1.4 Model 2
In this model, the free binding energy values were higher in general, ranging from ´9.17 to
´4.91 kcal¨mol´1, with the lowest ∆G value corresponding to the analog dcSTX, followed by GC6,
GC2, GC3a, GC6a, decarbamoyl neosaxitoxin (dcNEO), GC3, STX, and NEO, analogs that had the
lowest binding energy values, with ∆Gs ranging from ´8.19 to ´7.13 kcal¨mol´1. In this case, the
known most potent analogs (STX, NEO and dcSTX) showed (as expected) a lower ∆G value in
comparison with the less potent analogs, but along with these well-known toxic molecules, some GC
toxins of unknown toxicity showed low energy values as well (Figure 8). For each structural family,
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toxins;  gray  bars,  decarbamoyl  toxins;  diagonal  hatching,  benzoyl  toxins.  The most  potent  PST, 
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Figure 8. Free-binding energy (∆G, kcal¨ mol´1) of the docked toxins with Model 2. Toxins are grouped
according to their lateral chain: empty bars, carbamoyl toxins; horizontal hatching, N-sulfocarbamoyl
toxins; gray bars, decarbamoyl toxins; diagonal hatching, benzoyl toxins. The most potent PST,
saxitoxin (STX), is shown in the dotted bar. Numbers indicate the lowest ∆G in each group compared
with that of STX.
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3. Discussion
Despite knowledge of the basic structures and origin of the benzoyl STX analogs for over
two decades [9], there have been few targeted efforts to determine associated properties, including
mammalian toxicity, receptor-binding affinities and biological action mechanisms. These challenges
remain unmet because of the lack of a comprehensive suite of analytical standards, which in turn is a
function of the difficulty in their isolation and purification from G. catenatum cultures.
The alternative strategy to explore these properties was to use computational tools, including
structural analysis to decipher their binding recognition properties and to explore their non-bonding
interactions and ∆G values. Molecular docking studies of PSTs have already proven successful for
exploring and interpreting hindrance, electrostatic, and complementary shape properties between
receptors and ligands, and have also provided ∆G values and binding poses [26]. The docking
modeling approach has the potential to reveal, in great structural detail, the molecular interactions,
mechanisms, and structural contacts involved in binding recognition, which are not easily deduced
from electrophysiological experiments [27]. Previous computational studies have been able to
reproduce many of the experimental observations, including the binding affinity and specificity of a
given ligand, such as a toxin analog, in several subfamilies of ionic channels [27]. Docking simulations
allow fast screening of many ligands for a given protein [28,29], although their accuracy is limited [30].
From these studies, it is possible to obtain important information about the mode of action and the
affinity for the ligands, which helps explain, at least in part, the toxicity of diverse molecules, prior to
in vivo or in vitro testing.
Some computational studies of Nav channel-binding affinities of pore-blocking toxins have
accessed homology models to build the channel, as well as molecular docking simulations for
theoretical validation. Models of the mechanism and binding modes of pore-blocking toxins have
been proposed, but the exact binding modes between toxins and Nav channels have not yet been
elucidated [27].
Free binding energy (∆G, kcal¨mol´1) values given by these simulations are the result of
ligand-residue interactions, and thus serve as an intermolecular affinity indicator. The ∆G is the
sum of non-covalent interactions, as well as the planar and dihedral angles, and atomic bonds, all
physical properties described elsewhere in the force fields, and which make the most energetically
important contribution. The lowest ∆G values indicate the highest affinity between the ligand and the
protein [31]. Since the ∆G of the ligand-protein complex is the ultimate determinant of binding affinity,
predicting this value is the most important goal of the theoretical and computational studies.
3.1. Interactions with Nav Residues
Previous studies showed the importance of the acidic residues to the binding properties, whereby
carboxylic acid side chains are located in the same structural positions (toward the channel) in the
four domains to which STX binds [21,32]. In our study, in the simulation with Model 1, we observed
the interaction of STX and its analogs with the side chain D400 and K1237 at >90%. With other acidic
residues, E403, E755, and E758, the frequency of interaction was >80% (Figure 1). The residue K1237
was the second most accessed, with 92% of all the analogs interacting with this residue. Only residue
D400 had a slightly higher percentage (94%) of interactions with STX and analogs (Figure 1). Where the
sulfate group is absent, the main non-bond interactions are between the guanidinium group and acidic
residues, creating electrostatic interactions, whereas for those STX analogs where the sulfate group is
present (GTX4, C2, GC1, and GC1b), the main non-bond interactions are between the sulfate group
and basic residues, again yielding electrostatic interactions.
With Model 2, D400 and K1237 were also the residues with the most interactions, with >80% of the
analogs interacting with them. The other residues of the DEKA ring, however, showed less interactions
than in Model 1, with F1236 and C753 the most accessed residues after D400 and K1237 (78% and 76%
of the analogs interacting, respectively) (Figure 3). Even though there were fewer interactions with
the DEKA ring residues, the analogs interacted with a greater diversity of residues. As depicted for
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Model 1, the main non-bond interactions are between the guanidinium group and acidic residues,
whereas for STX analogs where the sulfate group is present (i.e., B2) the main non-bond interactions
are between the sulfate group with basic residues. In both cases, these interactions are electrostatic,
whereas for GC5b hydrogen bonds are generated with S1266 (Figure 4).
Based on these binding pose data, we postulate that STX and its analogs access the Nav1.4
primarily via electrostatic interactions, which are dominant (lowest ∆G values) among the non-covalent
interactions between ligands and proteins [33]. These kinds of interactions could also explain the high
affinity and relative toxicities of these PSTs, as has been demonstrated for other toxins [34].
3.2. Free-Binding Energy and Specific Toxicity
In Model 1, ∆G of the most potent analog according to mammalian intraperitoneal bioassays
(Table 1), STX, was ´12.1 kcal¨mol´1, similar to or even greater than that of other STX analogs.
In comparing free energy values of toxins with markedly different toxin potency, such as the
N-sulfocarbamoyl C2 (∆G ´14.1 kcal¨mol´1) versus STX, it is important to note that its molar toxicity
is about 1/10 of that of STX (Table 1). This difference could be caused by the higher molecular
weight of C2 compared with STX, and hence a larger surface interaction in the simulation with Nav1.4.
Under physiological conditions, the higher molecular weight of C2 could also affect its passage through
lipid-protein barriers thereby diminishing its toxic properties. Alternatively, its lower toxicity could be
the result of the compensated charges due to the two sulfate groups with negative charges, making
this molecule electrochemically neutral, whereas for STX the lack of sulfate groups leaves its positive
guanidinium charges uncompensated.
Table 1. Relative acute toxicities of saxitoxin and derivatives according to intraperitoneal mouse
bioassays, modified from Munday (2014) [25]. Relative values calculated from * Sullivan et al.,
(1985) [35] and ** from Oshima (1995) [36].



















From the toxin analogs that showed lower ∆G values with Model 1 (GTX4, C2, dcSTX, GC1,
GC3a and GC1b) (Figure 7), four have the double-negatively charged sulfate moiety at R2 or R3 (See
Materials and Methods). The negative charge could therefore increase the affinity by electrostatic
interactions with K1237 in the simulation.
In the simulation with Model 2, the overall ∆G values were higher, but these values showed
slightly better accordance with the actual potency of the analogs that have been subjected to in vivo
toxicity tests, as shown in Table 1. In this simulation, the analogs with lower ∆G were those with
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higher toxicity, such as STX and dcSTX (∆G values = ´7.31 and ´9.17 kcal¨mol´1, respectively), and
toxin B2 (∆G value = ´6.64 kcal¨mol´1). Though the differences among ∆G values of highly potent
toxins STX and dcSTX and the less potent B2 is small in our simulation, we found that this model
shows a slightly better correspondence than with Model 1. According to this Model 2 simulation,
the GC analogs with lowest ∆G values, GC6, GC3a and GC5b, could be then the most toxic analogs
of this toxin family. In their docking simulations, Choudhary and coworkers [32] found that the
gonyautoxins (GTX), the C-11 sulfated STX analogs, were approximately three-fold less potent than
their non-sulfated counterparts. Furthermore, the presence of N-1-OH conferred better binding to the
Nav channel with a sulfate group at C-11 (e.g., GTX1,4) than when this group is absent from this site
(e.g., NEO). Significantly, they found that a sulfate group at C-11 interacted mainly with the acidic
residues E758 and D1241.
In our study, in the simulation with Model 1, we found a lower binding energy for non-sulfated
C-11 toxins than for sulfated C-11 toxins, a difference of ´1.2 kcal¨mol´1. With Model 2, there were
no differences between C-11 sulfated and non-sulfated analogs. We did find that the sulfate group
creates electrostatic interactions with K1237. It is important to consider the molecular dimensions
in the context of blocking efficacy and binding affinities that are dependent upon charge- and steric
hindrance-effects. For example, the structural dimensions of the STX crystal are 8.5 ˆ 4 ˆ 6.5 Å, which
is increased by almost 6 Å along the major axis in benzoyl analogs. Despite the larger size of the
benzoyl analogs, they do fit into the Nav central cavity, as observed in in vitro studies [1,18]. Hence, this
cavity is large enough to host these toxins.
Chen and Chung [37] found that the peptide µ-conotoxin PIIIA in the outer vestibule of the
voltage-gated sodium channel NavAb is capable of blocking the channel by various binding modes,
despite its large molecular size (over 20 amino acids, ~2500 Da). The same mechanisms are plausible
for the STX analogs, which are smaller molecules (~300–569 Da) than the peptide toxins, thereby
allowing more free movement in the Nav channel, and reaching positively or negatively charged
amino-acid residues. With this docking study we were able to demonstrate different binding modes
for toxins with similar free binding energies, and not a single mode, as is generally assumed, and that
alternative binding modes were equally probable.
All STX analogs bind to the same site, although with different binding modes and affinities [22].
These theoretical observations were confirmed in our study. However, we found no direct relationship
between binding affinity and toxin potency, likely because biological properties that influence
pharmacokinetic parameters, including the quantity of molecules reaching the targets after crossing
biological barriers, are not considered in docking studies. The molecular movements in aqueous
systems or within lipid membranes are dependent upon atomic charge interactions capable of forming
hydrogen bonds with water molecules [38]. The target molecules vary according to their substituents,
which affect ligand recognition and also influence their biological availability, and consequently, the
quantity that reaches the protein target. These factors have to be considered when relating chemical
properties with the biological (toxicity) aspects of the STX analogs.
Llewellyn [39] performed a study of quantitative structure-relationship activity (QSAR) to use
molecular descriptors to describe the potency of known natural toxins and predict the toxicity
of untested natural STX analogs. This study [34] did not consider the binding properties, which
could yield differential affinity values related to blocking potency and, consequently, toxicity effects.
Nevertheless, he found a relationship between the molecular descriptors and toxicity properties of
PSTs and evidence linking sodium channel affinity of PSTs and toxicity, even though the relationship
was not linear or direct and differed among the different sodium channel isoforms. This variation
occurs because each sodium channel isoform has different residues that form the channel tunnel,
thereby affecting toxin recognition.
Our docking study provides critical information in clarifying the binding mechanism of STX
and its analogs on the Nav1.4 on two different conformations, determining the binding poses and
∆G values, without experimental assays. In rat synaptosomes, benzoyl STX analogs strongly bind to
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the channels, with less potency than STX [18]. In our docking simulations, we found that 12 benzoyl
analogs bound strongly to the Nav1.4 channel according to Model 1, and five analogs with Model 2,
all of them having a lower ∆G than STX (Figures 7 and 8). Again, the absence of direct correlation
between ∆G and toxin potency could result from not considering external biological parameters that
modify channel behavior, such as water and lipid components. Such factors are associated with
pharmacokinetic behavior and ligand recognition processes, including molecular movements that are
not considered in docking studies. Protein movement is important, as depicted in this docking study,
for which Model 1 and Model 2 showed somewhat different but not incompatible docking results,
with prominent electrostatic interactions, despite interactions with different residues in either model.
It is important to bear in mind that there is a huge difference between voltage-gated sodium
channel binding and whole animal toxicity. Furthermore, our simulation was performed with only one
of the many types of Nav channels, and, as has been recently demonstrated for several Nav human
channels, the response to STX and its analogs is channel-type dependent [40]. We recognize that
although there are major biological factors that are not taken into account by docking simulations,
this approach can describe comparative binding properties of toxins on the Nav channel at the atomic
level with approximate free energy values. These data can be compared with toxicity data as analytical
standards for novel toxin analogs become available for structural and potency analysis.
4. Conclusions
Even with the lack of experimental data on toxicity for several novel and poorly known STX
analogs, including benzoyl variants produced by G. catenatum, our simulations of binding behavior
predict that at least some of them would be toxic because they reach key residues by electrostatic
interactions. This poses challenges for human health protection, where blooms of G. catenatum occur
in waters from which shellfish are harvested, because these compounds are not subject to routine
analysis and quantitative toxin risk remains unknown. Although our in silico studies do not show a
linear relationship between theoretical and experimental data on toxin affinities for the Nav channel
and biological potencies, our simulation constitutes the first modeling of benzoyl-type paralytic toxins.
Our simulations describe the main interactions that could define the relationship of the molecule
to its specific toxicity, although better Nav models or different in silico techniques, with reference
to molecular dynamics or quantitative structure–activity relationships, are required to define linear
correlations to assess and predict specific toxicity of these analogs in a more reliable way. In any case,
this docking simulation approach contributes to a better understanding of the mode of action of STX
and its analogs, and indicates that the principal binding mechanism that governs ligand recognition is
mediated by electrostatic interactions.
5. Materials and Methods
5.1. Voltage-Gated Sodium Channel Models
The first model (dubbed Model 1) of the Nav1.4 outer vestibule (Robert J. French, Department of
Physiology & Pharmacology, University of Calgary, Calgary, Canada, personal communication) was
generated following the approach of Lipkind and Fozzard [41]. This channel building method employs
the S5 and S6 backbone coordinates and the pore helices from the KcsA bacterial potassium channel
and is supported with functional biophysical data [16]. This model was validated by exploring the
recognition of tetrodotoxin (TTX), 11-SO3-STX, and µ-conotoxins at binding site 1, which is located in
the α subunit of the channel [16]. Here, we used this model to perform the docking simulations in
triplicate to obtain average values and standard deviations of all energy calculations (Figure 9).
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The second model (Nav1.4 Model 2), proposed by Mahdavi and Kuyucak [19], was also
constructed by homologation with the crystal structure of the bacterial Nav, and validated with
functional data for binding of µ-conotoxin GIIIA. Both models have been applied for simulations
with µ-conotoxin GIIIA, and subjected to molecular dynamic analysis, yielding good results with
the conotoxin.
Model 2 is slightly more complex than Model 1, although there are no major differences between
them. We used this latter refined model for one docking simulation to compare results with those
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The alignments used for both models and their differences are shown in Table 2.
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Table 2. Alignments of P-loops from domains I–IV used for each model. Differences between the two
models are noted in red. The DEKA residues in the four domains forming the selectivity filter are
highlighted. Modified from [16,19].
Model 1 Domain I 385
400
409TFSWAFLALFRLMTQDYENLFQLT
Model 2 383 YDTFSWAFLALFRLMTQDYENLFQLTLRA 412
Model 1 Domain II 740
755
765DFFHSFLIVFRILCGEWIETMWDCMD
Model 2 738 MNDFFHSFLIVFRILCGEWIETMWDCMEVA 767
Model 1 Domain III 1222
1237
1246NVGLGYLLQVATFKGWMDIMYAA
Model 2 1220 YDNVGLGYLLQVATFKGWMDIMYAAVDS 1249
Model 1 Domain IV 1514
1529
1536TFGNSIICLFEITTSAGWDGLLN
Model 2 1512 FETFGNSIICLFEITTSAGWDGLLNPILNS 1541
5.2. Molecular Docking Simulations
Docking simulations were based upon the proposed structures of STX and analogs (Figure 11),
some of which have not been structurally confirmed, but rather inferred from mass spectrometry
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Figure 11. Molecular structures of STX and its analogs produced by G. catenatum. All of the analogs
depicted were subjected to in silico modeling simulations in our study. Structures marked with
* have only been inferred from mass spectrometry analysis [11] but are assumed to be correct for
docking simulations.
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The tridimensional structures of ligands were developed with GAUSSVIEW 5.0 software [42].
We obtained the conformation associated with the lowest energy and the highest stability by structural
optimization at the AM1 semi-empirical level by GAUSSIAN 3.0 software [43]. Once the structures
were energetically stable, we performed the docking simulations with AUTODOCK 4.0.1. [44]. In the
docking simulations, the protein was kept rigid and the docked ligands were considered flexible.
The grid box was set at 60 ˆ 60 ˆ 60 Å3 and centered on the channel orifice, considering the external
vestibule of the Nav1.4 α-subunit, where binding site 1 is located [45]. We chose the Lamarckian genetic
search algorithm for the best ligand conformation, and considered a set of 100 best conformers for each
ligand. With Nav1.4 Model 1, we ran the docking simulations in triplicate, each time with a different
computer, thereby obtaining 300 simulations for each ligand (10,500 simulations). We calculated an
average of the lowest three free binding energy (∆G) values per ligand. For comparison with Nav1.4
Model 2, we ran only one docking simulation, but again considered a set of 100 best conformers for
each ligand. Molecular docking results were analyzed with AUTODOCK TOOLS 1.5.6. [46] and figures
were created with VMD 1.9.1 software [47].
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